aTyr Pharma to Present at Jefferies 2017 Global Healthcare Conference
May 31, 2017 13:09 pm UTC| Business
SAN DIEGO, May 31, 2017 -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the...
aTyr Pharma to Present at Jefferies 2017 Global Healthcare Conference
May 31, 2017 13:09 pm UTC| Business
SAN DIEGO, May 31, 2017 -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the...
aTyr Pharma to Present at Jefferies 2017 Global Healthcare Conference
May 31, 2017 13:09 pm UTC| Business
SAN DIEGO, May 31, 2017 -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the...
aTyr Pharma to Present at Jefferies 2017 Global Healthcare Conference
May 31, 2017 13:09 pm UTC| Business
SAN DIEGO, May 31, 2017 -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the...
aTyr Pharma to Present at Jefferies 2017 Global Healthcare Conference
May 31, 2017 13:09 pm UTC| Business
SAN DIEGO, May 31, 2017 -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the...
aTyr Pharma to Present at Jefferies 2017 Global Healthcare Conference
May 31, 2017 13:09 pm UTC| Business
SAN DIEGO, May 31, 2017 -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the...
aTyr Pharma to Present at Jefferies 2017 Global Healthcare Conference
May 31, 2017 13:09 pm UTC| Business
SAN DIEGO, May 31, 2017 -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the...